RX695 RX695 (Minocycline Hydrochloride 75 mg)
Pill with imprint RX695 RX695 is Gray, Capsule-shape and has been identified as Minocycline hydrochloride 75 mg. It is supplied by Ranbaxy Pharmaceuticals Inc..
Minocycline is used in the treatment of acne; bacterial infection; skin or soft tissue infection; actinomycosis; rosacea (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 75 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for RX695 RX695
Minocycline hydrochloride
- Imprint:
- RX695 RX695
- Strength:
- 75 mg
- Color:
- Gray
- Size:
- 16.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Tetracyclines
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Ranbaxy Pharmaceuticals Inc.
- Inactive Ingredients:
- gelatin
titanium dioxide
propylene glycol
shellac
potassium hydroxide
corn starch
ferric oxide black
magnesium stearate
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 13668-0483 | Torrent Pharmaceuticals Limited |
More about minocycline
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 412 Reviews – Add your own review/rating
- Drug class: tetracyclines
Consumer resources
- Minocycline
- Minocycline Capsules
- Minocycline Extended-Release Tablets
- Minocycline Extended-Release Capsules
- Minocycline Tablets
- ... +4 more
Other brands: Minocin, Solodyn, Dynacin, Ximino, ... +3 more
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
